|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.308 SEK | -1.91% |
|
-10.98% | -24.51% |
AlphaHelix Molecular Diagnostics AB (publ) reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was SEK 26.1 million compared to SEK 34.33 million a year ago. Revenue was SEK 26.67 million compared to SEK 34.68 million a year ago.
Net loss was SEK 9.48 million compared to SEK 2.22 million a year ago. Basic loss per share from continuing operations was SEK 0.15 compared to SEK 0.04 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -24.51% | 1.83M | |
| +7.84% | 218B | |
| +7.35% | 183B | |
| +13.04% | 134B | |
| +26.03% | 106B | |
| -1.33% | 61.12B | |
| +4.81% | 50.89B | |
| +0.30% | 40.3B | |
| +2.78% | 35.53B | |
| +26.14% | 32.05B |
ALPHAHELIX MOLECULAR DIAGNOSTICS AB 
